Natco Pharma today reported 15.63 per cent dip in consolidated net profit to Rs 28.23 crore for the first quarter ended June 30, 2015-16.
It had posted net profit of Rs 33.46 crore for the April- June period last fiscal.
The company's total income from operations rose to Rs 223.71 crore for the quarter under consideration, as against Rs 209.96 crore for the year-ago period.
In a separate filing on the BSE, Natco Pharma said its Board of Directors has approved the sub-division of face value of equity shares from Rs 10 each to that of Rs 2 each and enhancement of limits of borrowing powers.
Natco stock closed at Rs 2,410.65, down 2.38 per cent, on the BSE.
